NAUT Nautilus Biotechnology, Inc.

8mon ago, source: Seeking Alpha

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company ...

Nautilus Biotechnology Inc (NAUT) Reports Fiscal Year 2023 Financial Results

1mon ago, source: Yahoo Finance

Warning! GuruFocus has detected 1 Warning Sign with NAUT. On February 28, 2024, Nautilus Biotechnology Inc (NASDAQ:NAUT) released its 8-K filing, detailing the financial results for the fourth quarter ...

Nautilus Biotechnology earnings beat by $0.02, revenue was in line with estimates

1mon ago, source: Investing

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Nautilus Biotechnology, Inc. (NAUT)

12d ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Nautilus Biotechnology Inc Ordinary Shares

20d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Nautilus Biotechnology Inc Ordinary Shares NAUT

9d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Nautilus Biotechnology

29d ago, source: Labroots

Nautilus Biotechnology seeks to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. By integrating ...

Nautilus Biotechnology Inc.

27d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Nautilus Biotechnology Inc.

8mon ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Nautilus Biotechnology, Inc. (NAUT)

9d ago, source: Yahoo Finance

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...